Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.
暂无分享,去创建一个
Nicholas D. Camarda | S. Carter | J. Davison | A. Bass | M. Ducar | A. Thorner | M. Redston | R. Odze | A. Noffsinger | J. Hornick | A. Agoston | R. Lash | M. Stachler | Christopher Deitrick | Anwesha Nag | A. Kim
[1] Icgc,et al. Pan-cancer analysis of whole genomes , 2017, bioRxiv.
[2] Benjamin J. Raphael,et al. The evolutionary history of 2,658 cancers , 2017, Nature.
[3] R. Fitzgerald,et al. The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma. , 2017, Gastroenterology.
[4] A. Krasinskas,et al. The Use of Ancillary Stains in the Diagnosis of Barrett Esophagus and Barrett Esophagus-associated Dysplasia: Recommendations From the Rodger C. Haggitt Gastrointestinal Pathology Society. , 2017, The American journal of surgical pathology.
[5] G. Ergun,et al. p53 protein accumulation predicts malignant progression in Barrett's metaplasia: a prospective study of 275 patients , 2017, Histopathology.
[6] J. Xiong,et al. Meta‐analysis of biomarkers predicting risk of malignant progression in Barrett's oesophagus , 2017, The British journal of surgery.
[7] J. Tijssen,et al. Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia. , 2017, Gastroenterology.
[8] L. Macconaill,et al. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer. , 2017, Archives of pathology & laboratory medicine.
[9] Marian Harris,et al. Institutional implementation of clinical tumor profiling on an unselected cancer population. , 2016, JCI insight.
[10] M. Ilyas,et al. Dysplasia in Barrett's oesophagus: p53 immunostaining is more reproducible than haematoxylin and eosin diagnosis and improves overall reliability, while grading is poorly reproducible , 2016, Histopathology.
[11] F. Wians,et al. Healthcare Cost of Over-Diagnosis of Low-Grade Dysplasia in Barrett’s Esophagus , 2016, Advances in Therapy.
[12] Nicholas J Shaheen,et al. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus , 2016, The American Journal of Gastroenterology.
[13] P. Martinez,et al. Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagus , 2015, Gut.
[14] S. Tavaré,et al. Whole-genome sequencing provides new insights into the clonal architecture of Barrett’s esophagus and esophageal adenocarcinoma , 2015, Nature Genetics.
[15] A. Sepulveda,et al. Evaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus. , 2015, The Journal of molecular diagnostics : JMD.
[16] Patricia L. Blount,et al. Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus , 2015, Cancer Prevention Research.
[17] P. Martinez,et al. Derivation of genetic biomarkers for cancer risk stratification in Barrett’s oesophagus: a prospective cohort study , 2015, Gut.
[18] A. McKenna,et al. Paired Exome Analysis of Barrett’s Esophagus and Adenocarcinoma , 2015, Nature Genetics.
[19] M. Styn,et al. The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus , 2015, The American Journal of Gastroenterology.
[20] M. Stratton,et al. High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.
[21] P. Fockens,et al. Aberrant TP53 detected by combining immunohistochemistry and DNA‐FISH improves Barrett's esophagus progression prediction: A prospective follow‐up study , 2015, Genes, chromosomes & cancer.
[22] Jan G P Tijssen,et al. Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel , 2014, Gut.
[23] Rebecca C Fitzgerald,et al. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis , 2014, Nature Genetics.
[24] Zoltan Szallasi,et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. , 2014, Cancer discovery.
[25] Carissa A. Sanchez,et al. Temporal and Spatial Evolution of Somatic Chromosomal Alterations: A Case-Cohort Study of Barrett's Esophagus , 2013, Cancer Prevention Research.
[26] E. Kuipers,et al. Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus , 2012, Gut.
[27] L. Wernisch,et al. DNA Methylation as an Adjunct to Histopathology to Detect Prevalent, Inconspicuous Dysplasia and Early-Stage Neoplasia in Barrett's Esophagus , 2012, Clinical Cancer Research.
[28] A. McKenna,et al. Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.
[29] Jashanpreet Singh,et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis , 2011, Gut.
[30] Kenneth K Wang,et al. Genome-Wide Catalogue of Chromosomal Aberrations in Barrett's Esophagus and Esophageal Adenocarcinoma: A High-Density Single Nucleotide Polymorphism Array Analysis , 2010, Cancer Prevention Research.
[31] G. Meijer,et al. Low-Grade Dysplasia in Barrett's Esophagus: Overdiagnosed and Underestimated , 2010, The American Journal of Gastroenterology.
[32] A. Axon,et al. A study of indefinite for dysplasia in Barrett’s oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (α‐methylacyl‐CoA‐racemase) , 2010, Histopathology.
[33] A. Bhattacharyya,et al. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. , 2009, Cancer research.
[34] Carissa A. Sanchez,et al. p16 Mutation Spectrum in the Premalignant Condition Barrett's Esophagus , 2008, PloS one.
[35] W. Chow,et al. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. , 2008, Journal of the National Cancer Institute.
[36] R. Holmes,et al. Epidemiology and pathogenesis of esophageal cancer. , 2007, Seminars in radiation oncology.
[37] M. Trková,et al. TP53 Gene Mutations Are Rare in Nondysplastic Barrett's Esophagus , 2006, Digestive Diseases and Sciences.
[38] Michael Vieth,et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. , 2005, Gastroenterology.
[39] David Pellman,et al. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells , 2005, Nature.
[40] O. Kocher,et al. Evaluation of p53 mutations in premalignant esophageal lesions and esophageal adenocarcinoma using laser capture microdissection , 2004, Modern Pathology.
[41] Patricia L. Blount,et al. The Combination of Genetic Instability and Clonal Expansion Predicts Progression to Esophageal Adenocarcinoma , 2004, Cancer Research.
[42] R. Sutton,et al. TP53 mutations in malignant and premalignant Barrett's esophagus. , 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[43] G. Jenkins,et al. Early p53 mutations in nondysplastic Barrett's tissue detected by the restriction site mutation (RSM) methodology , 2003, British Journal of Cancer.
[44] Patricia L. Blount,et al. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. , 2001, Cancer research.
[45] J. Goldblum,et al. The Location and Frequency of Intestinal Metaplasia at the Esophagogastric Junction in 223 Consecutive Autopsies: Implications for Patient Treatment and Preventive Strategies in Barrett's Esophagus , 2000, Modern Pathology.
[46] R. Tarone,et al. Frequent clones of p53-mutated keratinocytes in normal human skin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[47] J. Roth,et al. Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. , 1996, The Journal of thoracic and cardiovascular surgery.
[48] G Van Belle,et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.